Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03960931
Other study ID # 2019-A00753-54
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2019
Est. completion date November 30, 2021

Study information

Verified date June 2019
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Parkinson Disease (PD) is a neurodegenerative disorder who begin around 55 years old, characterized by brain's backmatter's dopamine neuron destruction, involved in motor control. Diagnosis is made with presence of 3 of 4 disease's cardinal sign: bradykinesia, rigidity, resting tremor, walking troubles. Treatments enhance patient's quality of life, but do not allow to stop disease's evolution, who is specific depending on a lot of factors. For some years, PD's non motor symptoms (NMS) - in particular pain, anxiety, depression, sleep disorders - have been highlighted and turn out to impair sometimes quality of life even though motor symptoms are controlled. This project's main aim is to evaluate if aquatic environment's care lead to an advantage on PD's NMS, symptoms currently underestimated, insufficiently in care and having a harmful influence on quality of life. Collaboration of the University Hospital (Neurology Dpt), the Physical Medicine and Rehabilitation Regional Institute, Grand Nancy Thermal, and France Parkinson Association, will allow in this way to offer on PD's NMS, postural control impairments, and walking troubles an alternative or further non-pharmacological therapy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 126
Est. completion date November 30, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria, patient:

- having get a complete information on study's organization and having given written informed consent,

- affiliated to a social security system,

- suffering from Parkinson's disease (stage 2 or 3 of Hoehn and Yahr),

- with motor fluctuation lower than 25% of awaked time,

- with dyskinesia lower than 25% of awaked time (according to MDS-UPDRS scale),

- with stable pharmacological treatment during the 30 days before study,

- already benefiting of a physiotherapy.

Exclusion Criteria, patients:

- receiving treatment by apomorphine or Duodopa pump,

- benefiting of brain stimulation,

- taking occasionally benzodiazepine,

- with dementia (MDS-UPDRS 1.1 score > 3),

- having had a sprain on a lower limb joint 3 months or less before the beginning of study,

- having head trauma consequences,

- having vertebrae pain,

- with freezing,

- having skin trouble leading to a contraindication of aquatic activities,

- concerned by L. 1121-5, L. 1121-7 and L 1121-8 articles of French public health code.

Study Design


Related Conditions & MeSH terms

  • Interest of Hydrophysiotherapy Care in Parkinson Disease's Non-motor Symptoms
  • Parkinson Disease

Intervention

Other:
Aquatic rehabilitation
Rehabilitation sessions using hydrophysiotherapy will occur in a pool of Grand Nancy Thermal, three times per week during 4 weeks, and each will last 45 min. They will begin with 10 min of warm-up, then 30 min of walking. Sessions will end cool-down during 5 min, which will be a reduction of intensity every 30 sec. Rehabilitation will be carried out by physiotherapist chosen for the study.
Land based physical activities
Rehabilitation sessions on treadmill will occur at Physical Medicine and Rehabilitation Regional Institute (IRR), on the University Hospital's site, three times per week during 4 weeks, and each will last 45 min. They will begin with 10 min of warm-up, then 30 min of walking, where intensity of effort can be modulated by speed and inclination of treadmill. Sessions will end cool-down during 5 min, which will be a reduction of intensity every 30 sec. Rehabilitation will be carried out by physiotherapist chosen for the study.
Conventional rehabilitation
Conventional rehabilitation sessions will occur in private practices in which patients receive their habitual care (same physiotherapist). This care will be guided by prescription delivered by the neurologist. This prescription suggests to work on active and passive upper and lower limb stretching, on hip and shoulder dissociation, and balance control management on unstable ground.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Central Hospital, Nancy, France Institut Régional de Médecine Physique et de Réadaptation

Outcome

Type Measure Description Time frame Safety issue
Primary Change of score on Parkinson's Disease Questionnaire 39 (PDQ 39) after reeducation Total score to PDQ 39 (between 0 and 156, a lower score being a better outcome), which evaluates quality of life, before and after reeducation Day 1, day 28 (+7)
Secondary Persistence of change of score on PDQ 39 after reeducation Total score to Parkinson Disease Questionnaire 39 (between 0 and 156, a lower score being a better outcome), which evaluates quality of life, before and after reeducation. Day 28(+7), day 56 (+/-7)
Secondary PDQ 39 sub-scores Sub-score for each of the 8 fields composing PDQ 39: mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication and bodily discomfort Day 1, day 28 (+7), day 56 (+/-7)
Secondary Non-Motors Signs (NMS) Questionnaire score Questionnaire score for NMS (non motor signs) in its globality. Day 1, day 28 (+7), day 56 (+/-7)
Secondary Parkinson Anxiety Scale (PAS) score Parkinson's Anxiety Scale, evaluating anxiety (between 0 and 30, a lower score being a better outcome). Day 1, day 28 (+7), day 56 (+/-7)
Secondary Parkinson's Disease specific Pain score King's Parkinson's Disease Pain Scale (KPPS, between 0 and 168, a lower score being a better outcome) Day 1, day 28 (+7), day 56 (+/-7)
Secondary Global Pain score Visual Analogic Scale (VAS) (between 0 and 10, a lower score being a better score) Day 1, day 28 (+7), day 56 (+/-7)
Secondary Mean Equilibrium path length Corresponding to the mean path length travelled by displacement of the Centre of Foot Pressure in four conditions (eyes open or closed, firm or foamed support). Day 1, day 28 (+7), day 56 (+/-7)
Secondary Mean Equilibrium ellipse area Corresponding to the mean ellipse area covered by displacement of the Centre of Foot Pressure in four conditions (eyes open or closed, firm or foamed support) Day 1, day 28 (+7), day 56 (+/-7)
Secondary Ratio of sensory inputs. Ratio of sensory inputs in postural control (somatosensory, visual and vestibular ratios). Day 1, day 28 (+7), day 56 (+/-7)
Secondary Entropy Entropy mathematically evaluates the displacements regularity of the Center of Foot Pressure (CoP). If the CoP displacements are regular (lower entropy), intentionally processes are more implicated in postural control regulation. If the CoP displacements are not regular (higher entropy), automatic processes are more implicated in postural control regulation. Entropy comparison between a single and a dual task is analyzed. Day 1, day 28 (+7), day 56 (+/-7)
Secondary Time for Time Up and Go (TUG) Timed Up and Go Day 1, day 28 (+7), day 56 (+/-7)
Secondary Distance of walking Distance walked during the 6 min walk test Day 1, day 28 (+7), day 56 (+/-7)
Secondary Walking velocity Mean velocity during the 6 min walk test. Day 1, day 28 (+7), day 56 (+/-7)
Secondary Step high Mean step high during the 6 min walk test. Day 1, day 28 (+7), day 56 (+/-7)
Secondary Step length Mean step length during the 6 min walk test. Day 1, day 28 (+7), day 56 (+/-7)
Secondary Step width Mean step width during the 6 min walk test. Day 1, day 28 (+7), day 56 (+/-7)
Secondary Subjective effort Ratio of Perceived Exertion (RPE) score, evaluated by Borg Scale (according to the 6 min walk test). Score is between 6 and 20, 6 being a better outcome. Day 1, day 28 (+7), day 56 (+/-7)